Stocks and Investing Stocks and Investing
Fri, October 22, 2021
Thu, October 21, 2021
Wed, October 20, 2021
Tue, October 19, 2021

Brian Skorney Maintained (VRTX) at Buy and Held Target at $240 on, Oct 19th, 2021


Published on 2024-10-27 18:14:16 - WOPRAI
  Print publication without navigation


Brian Skorney of Baird, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $240 on, Oct 19th, 2021.

Brian has made no other calls on VRTX in the last 4 months.



There are 6 other peers that have a rating on VRTX. Out of the 6 peers that are also analyzing VRTX, 2 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Paul Matteis of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $213 on, Thursday, September 9th, 2021
  • Danielle Brill of "Raymond James" Initiated at Hold on, Thursday, July 1st, 2021


These are the ratings of the 4 analyists that currently disagree with Brian


  • Matthew Harrison of "Morgan Stanley" Downgraded from Hold to Sell and Held Target at $202 on, Tuesday, September 7th, 2021
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $248 on, Friday, July 30th, 2021
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $323 on, Friday, July 30th, 2021
  • Geoffrey Porges of "SVB Leerink" Maintained at Sell with Increased Target to $175 on, Friday, July 30th, 2021